Sofinnova Ventures »

Rapport Therapeutics shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2024-06-30 $45M 2.0M 23.26

More positions owned by Sofinnova Ventures

Invesco QQQ TR Unit Ser 1 Put Option (QQQ)
Natera (NTRA)
Edwards Lifesciences (EW)
Vera Therapeutics Cl A (VERA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Novo-Nordisk A S Adr (NVO)
Stryker Corporation (SYK)
AstraZeneca Sponsored Adr (AZN)
Intuitive Surgical (ISRG)
Dyne Therapeutics (DYN)
Align Technology (ALGN)
Alnylam Pharmaceuticals (ALNY)
Rapport Therapeutics (RAPP)
Syndax Pharmaceuticals (SNDX)
Elanco Animal Health (ELAN)

View all positions for Sofinnova Ventures

Top funds holding Rapport Therapeutics

Arch Venture Corp
Cormorant Asset Management
Johnson & Johnson
Sofinnova Ventures
T. Rowe Price Investment Management
T. Rowe Price Associates
Alliancebernstein
Perceptive Advisors
Citadel Advisors
Artal Group
Logos Global Management
Woodline Partners
Millennium Management
TD Asset Management
Manufacturers Life Insurance Company

View all funds holding Rapport Therapeutics